Contraceptives market size was valued at $26,321.50 million in 2020, and is estimated to reach $50.6 Billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030.ย The use of advanced contraceptive methods and emergency contraceptives methods, especially for teenagers, and increase in awareness regarding sexually transmitted infections (STIs) are the major factors responsible for the growth of the contraceptives market. Increase in popularity of female condoms, custom-fit condoms, and other novel products fuels the demand for contraceptives, especially in developed regions. Furthermore, rise in adoption of modern contraceptives in the developing economies has significantly contributed to the market growth. However, sociocultural influences of contraceptives and side effects, such as infertility resulting from the use of contraception are the major impediments to the market growth.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
The report provides a comprehensive analysis of the key players that operate in the contraceptives market, namely, Veru Inc., Teva Pharmaceutical Industries Limited, Abbvie Inc., Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/451
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
Several manufacturers in the global contraceptives industry stopped their business activities in 2020 due to lockdowns implemented in developed and developing countries, owing to ban on industrial activities due to the COVID-19 pandemic. This halt in production activities impacted the revenue of the contraceptives manufacturing companies. For instance, net sales of Teva Pharmaceuticals Industries Limited dropped by 4.7% from January 2021 to December 2021. In addition, lack of man power and raw materials affected the supply chain of the global contraceptives market. However, the market is projected to cover from the 1st quarter of 2023, due to reduced restrictions and reopening of the global contraceptives industry. Moreover, in 2021, with the availability of vaccine against COVID-19, the market re-opened at full pace with a start of 2022.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/451
Contraceptives market analysis is done on the basis of age group, product type, and end user. On the basis of age group, women in the age group of 15โ24 years are the major revenue contributors to the contraceptive market. This is attributed to the increased usage of contraceptives among teenagers, early maturity among teenage girls, and rising demand for contraceptives. However, women aged above 44 years are the least contributors to the contraceptives market growth due to the menopause in women at the age 44 years and above. Above 44 years segment has highest contraceptives market share.
On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for majority share in the contraceptives market in 2020. This market is expected to maintain its lead during the forecast period due to increase in awareness among the population, upsurge in adoption of modern contraceptives, and rise in prevalence of sexually transmitted diseases such as HIV/AIDS. Contraceptives market forecast from 2020 to 2030.
The U.S. contraceptive market accounts for the largest share in the overall North America contraceptive market. Asia-Pacific region is expected to grow at the fastest pace during the study period, owing to high population base and proactive initiatives of governmental organization for birth control. Moreover, technological advancements and cost-effective contraceptive products in these regions offer lucrative opportunities to contraceptive manufacturers. Initiatives taken by regulatory bodies and government organizations to mandate the use of barrier contraceptives, such as condoms, have significant impact on the growth of the contraceptive market. Contraceptive methods for home use are effective and convenient, owing to the cost-effectiveness of these products. Advancements in contraceptive techniques and launch of awareness programs by government agencies and other regulatory bodies to increase household usage of contraceptives drive the markets in Asia-Pacific and LAMEA regions. Asia-Pacific region has highest contraceptives market size.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com